New York, New York Clinical Trials

A listing of New York, New York clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 416 clinical trials
A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine Cyclophosphamide and Rituximab (FCR)/ Bendamustine And Rituximab (BR) in FIT Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without DEL (17P) or TP53 Mutation

This study will evaluate the efficacy and safety of venetoclax and obinutuzumab (VEN + G) compared with fludarabine + cyclophosphamide + rituximab or bendamustine + rituximab (FCR/BR) in FIT participants (FIT is defined by a cumulative illness rating scale [CIRS]/score of 6 and a normal creatinine clearance of 70 mL/min) …

obinutuzumab
cyclophosphamide
neutrophil count
cytopenia
lymphoid leukemia
Regional Cancer Care Associates
 (6.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +50 other locations
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

The primary objective of this study is to demonstrate the non-inferiority of the vaccine seroresponse to meningococcal serogroups A, C, Y, and W following administration of 2 doses of MenACYW conjugate vaccine compared to 2 doses of MENVEO when given concomitantly with routine pediatric vaccines to infants and toddlers 6 …

Investigational Site Number 8400069
 (3.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +47 other locations
Phase 2 Study of SAR439859 Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer (AMEERA-3)

Primary Objective: To determine whether SAR439859 per os improves progression free survival (PFS) when compared with a endocrine monotherapy of the choice of the physician, in participants with metastatic or locally advanced breast cancer. Secondary Objectives: To compare the overall survival in the 2 treatment arms To assess the objective …

letrozole
cancer
advanced breast cancer
adenocarcinoma of the breast
locally advanced breast cancer
Investigational Site Number 8400025
 (6.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +130 other locations
Aging and Information Processing

The purpose of our study is to better understand functional differences in brain activity between healthy aging and neurodegenerative conditions, such as Alzheimer's Disease. To do this, our lab uses a noninvasive and inexpensive technique to collect brain measurements called electroencephalogram (EEG). By recording EEG while participants do certain memory …

AutoSite12071
 (7.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +8 other locations
Formal Test Trial 500 Site & User

Test comment here

A123
 (6.3 away) Contact site
  • 0 views
  • 09 Jul, 2026
  • +1 other locations
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis (FREVIVA)  

The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the disability progression and the safety up to approximately 51 months administration of study intervention compared to placebo in male and female participants with nrSPMS (aged 18 to 60 years at …

Holy Name Medical Center Site Number : 8400101
 (5.1 away)
  • 0 views
  • 04 Mar, 2025
  • +58 other locations
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma (AIRLYMPUS)

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this study is to assess the efficacy, safety, and tolerability of add-on therapy with SC lunsekimig compared with placebo in male and female participants (aged 18 to 80 years, inclusive) with asthma, …

Icahn School of Medicine at Mount Sinai - Mount Sinai Health System- Site Number : 8400069
 (3.4 away) Contact site
  • 0 views
  • 24 Nov, 2025
  • +50 other locations
Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

This study will assess the efficacy and safety of capivasertib plus abiraterone (+prednisone/prednisolone) plus androgen deprivation therapy (ADT) versus placebo plus abiraterone (+prednisone/prednisolone) plus ADT in participants with mHSPC whose tumours are characterised by PTEN deficiency. The intention of the study is to demonstrate that in participants with mHSPC, the …

prostate cancer
cancer
prednisolone
luteinizing hormone-releasing hormone agonist
antiandrogen therapy
Research Site
 (5.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +106 other locations
A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV

Many people living with HIV (PLWH) smoke. Smoking in these individuals is often undertreated. This study plans to assess the ability of various clinical pathways involving tobacco treatment medications and contingency management (paying smokers for not smoking) to improve smoking cessation in a group of PLWH.

smoking cessation therapy
tobacco use disorder
Icahn School of Medicine at Mount Sinai
 (3.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
Efficacy of Buprenorphine for Treatment of Acute Pain  

The purpose of this study is to determine whether sublingual buprenorphine is effective in the treatment of acute pain in adult patients with extremity bone fractures

acute pain
morphine
buprenorphine
xxxx@test.com
 (9.4 away)
  • 0 views
  • 20 Sep, 2024
  • +12 other locations